This year, we’re celebrating a decade of the Country 2 Country 4 Cancer (C2C4C) ride and our ongoing commitment to advancing cancer research. A team of eight Bristol Myers Squibb UK & Ireland riders took part in the 2023 event, forming a community of more than 90 riders, with colleagues representing 19 countries.
Collectively they tackled a 2,200km route in 18 days across several stages, with different teams cycling through Germany, Switzerland, France, Spain, and the UK. For the first time ever, riders from the Czech Republic, Poland, and Romania also participated.
The inaugural ride took place in the United States in 2014, and since then, approximately 550 Bristol Myers Squibb colleagues from the UK and across Europe have raised more than £2 million through the C2C4C ride.
This annual event is more than just a bike ride, it’s a reminder that patients are at the centre of what we do, as one team, every day. Patients are the reason BMS employees were inspired to create the C2C4C ride in 2014 and continue to raise money to fund and advance cancer research.
